The six-layered mammalian cerebral cortex is derived from neural stem and progenitor cells (NSPCs) in the embryonic ventricular zone (VZ) and subventricular zones (SVZ) (Kwan et al., 2012) . Radial glial cells (RGCs), which function as neural stem cells, generate neurons directly or indirectly through intermediate progenitor cells (IPCs) . Migrating away from the VZ and SVZ along the radial glial processes, early-born neurons transit through the intermediate zone (IZ) to form the deeper layers in the cortical plate, while lateborn neurons occupy the upper layers. Neural lineage development requires precise spatial-temporal control of gene expression to guarantee proper specification of neuronal subtypes, migration, and final positioning in the cortical layers (Kwan et al., 2012) .
Epigenetic modifiers, including enzymes that add or remove covalent modifications on DNA and histones, regulate activity of cis-regulatory elements (e.g., promoters and enhancers). In concert with transcriptional co-factors, epigenetic modifiers play an important role during neural development by regulating gene expression through DNA methylation and histone modifications (Yoon et al., 2018) . Similar to transcription profile, epigenetic modification patterns change as NSPCs differentiate into different cell types and are under tight temporal and spatial regulation. In this issue of Neuron, Baizabal et al. (2018) demonstrate how PRDM16 regulates upper-layer neurogenesis by embedding epigenetic information in RGCs to convey controls on the behavior of their progeny, in which PRDM16 is no longer present.
PRDM16 belongs to the large positive regulatory domain (PRDM) protein family that is structurally defined by a conserved N-terminal PR (PRD1-BF1 and RIZ1 homology) domain and repeated arrays of zinc fingers (Chi and Cohen, 2016) . The PR domain shares sequence and structure similarity to the SET domain found in many histone lysine methyltransferases. It has been shown recently that PRDM16 is able to catalyze monomethylation of histone 3 lysine 9 (H3K9) and histone 3 lysine 4 (H3K4) (Chi and Cohen, 2016) . PRDM16 also interacts with a number of transcriptional regulators to play a critical role in cell fate determination such as adipocyte specification. In the developing cerebral cortex, expression of Prdm16 is highly enriched in the VZ and diminished as RGCs progress through IPCs to differentiating neurons (Shimada et al., 2017; Baizabal et al., 2018) . Previous studies show that PRDM16 is required for adult neural stem cell maintenance and ependymal cell differentiation (Shimada et al., 2017) . In the embryonic cerebral cortex, PRDM16 is postulated to regulate mitochondria reactive oxygen species during neural development and affects neuronal differentiation and migration (Inoue et al., 2017) . However, the molecular mechanism remains largely unknown.
In order to study the function of PRDM16 in the developing cerebral cortex, Baizabal et al. (2018) To identify the transcriptional targets of PRDM16, the authors further investigated genome-wide distribution of PRDM16 by chromatin immunoprecipitation sequencing (ChIP-seq) at the time when upper layer neurons are being generated. PRDM16-binding sites are enriched mostly in distal intergenic regions and introns, rather than proximal regions to transcription start sites. Hence, PRDM16 could act on enhancers, distal cis-regulatory elements essential to control gene expression programs during development.
A recent genome-wide screen has identified thousands of embryonic forebrain enhancers, based on sequence conservation and ChIP-seq analysis using an antibody for the enhancer-associated protein p300. Many of these candidate enhancers are confirmed to have in vivo activities driving temporal and spatialspecific expression in the forebrain of transgenic mouse lines (Visel et al., 2013) . These distal-acting elements are often enriched with distinct histone modifications, such as H3K4me and H3K27ac, and binding motifs for transcriptional co-factors that are important for cell fate determination and differentiation (Creyghton et al., 2010) . Baizabal et al. (2018) show that PRDM16-binding sites are highly enriched with active enhancer histone modification, H3K27ac, and modestly associated with the poised and active enhancer marker H3K4me, suggesting that PRDM16 primarily binds to active enhancers. Furthermore, the majority of PRDM16-bound genomic regions are active enhancers only during cortical development. These findings bring about several questions: Does PRDM16 control enhancer activity during RGC development? If so, how does PRDM16 modulate enhancer state? Are changes in gene expression caused by loss of PRDM16 correlated with altered enhancer activities?
As a chromatin-modifying factor known to be able to catalyze H3K4 and H3K9 methylation in vitro (Chi and Cohen, 2016) , it is conceivable that PRDM16 might control the level of histone methylation in neural progenitor cells. Intriguingly, when the authors compared the distribution of H3K4me and H3K27ac in the genome between Prdm16 WT and cKO cortex, they did not detect overall changes in H3K4me level, but the levels of H3K27ac were dramatically changed in both known enhancers and promoters when Prdm16 is depleted in RGCs. Such changes are positively correlated with expression changes in cKO cortex in genes that are located within the associated genomic regions. Hence, PRDM16 regulates gene expression through modulating enhancer activity. Interestingly, this correlation between levels of H3K27ac modification and gene expression exists not only in RGCs where PRDM16 is expressed but also in the IPCs and neurons where PRDM16 is not expressed, suggesting regulation of PRDM16 on enhancer activities lasts through neural lineage development.
Based on analysis from RNA-seq, ChIP-seq of PRDM16, and histone modifications, together with in situ expression analysis and in vivo functional analysis comparing WT and cKO cortex, Baizabal et al. (2018) identified PDZRN3, an E3 ubiquitin ligase, as a direct target repressed by PRDM16. In the embryonic cortex, the expression level of Pdzrn3 is relatively low in the VZ and SVZ, and later reaches the peak in the IZ, then drops down in the cortical plate. The function of PDZRN3 in cortical development is unknown. In Prdm16 cKO cortex, Pdzrn3 is upregulated in the VZ, SVZ, and IZ, and in the heterotopias formed in the WM. Upregulation of Pdzrn3 is accompanied by increased level of H3K27ac at the promoter and enhancer regions. Overexpression of Pdzrn3 in the developing RGCs induces the migration defects similar to that in Prdm16 cKO, while knockdown of Pdzrn3 in Prdm16-silenced RGCs partially rescues the failure of upper layer neuron migration. These results clearly demonstrate that repression of Pdzrn3 by PRDM16 in RGCs is required for proper neuron migration.
As a histone methyltransferase, the PR domain of PRDM16 is responsible for establishing methylation on the lysine residues of histone H3, conveying epigenetic regulatory functions (Chi and Cohen, 2016) . Is this domain dispensable for PRDM16-regulated developmental processes in the cerebral cortex? Baizabal et al. (2018) The most fascinating power of epigenetic regulation is to unveil the rich variety of cellular identities and properties embedded in the same DNA sequence by setting up ordered and diversified transcriptional networks. Here, Baizabal et al. (2018) demonstrate that the temporal and cell-type-specific expression of epigenetic regulators like PRDM16 ensures correct cell types to be generated and moved to the right place. A recent study of histone methylation on five populations of FACS-sorted cortical cells has strongly suggested that different cell types in the developing cortex have distinct features of chromatin modification (Albert et al., 2017) . The study by Baizabal et al. (2018) would benefit from such cell-type-specific characterization of histone modifications to dissect out the exact cell types that are epigenetically regulated by PRDM16. The persistent influence on cell behavior without the presence of PRDM16 also brings about an interesting question: are the epigenetic modifications casted by PRDM16 in RGCs inherited by the daughter cells? Persistency of histone-modifying enzymes through DNA replication has been considered as a possible mechanism for the inheritance of histone modifications (Chen and Dent, 2014) . It would be interesting to see whether histone modifications associated with cell migration genes set up by PRDM16 are maintained in newborn neurons.
The complex nature of neural development requires interweaving of multiple layers of regulatory mechanisms. Nextgeneration sequencing techniques have greatly advanced our knowledge of gene expression profiles, epigenetic patterns, and chromatin states in NSPCs and their progeny. However, from the hay of gene lists and a plethora of binding peaks, how to find the needle that can interlace the missing links in the biological processes remains a major challenge. Perhaps analysis at the level of purified cell population, as Baizabal et al. have done, or even at single-cell resolution, may help resolve the ambiguity we often encounter when a heterogeneous or dynamically developing population such as neural stem cell lineage is experimented on. A clear understanding of cell-typeand developmental stage-specific mechanisms of epigenetic regulatory network would shed light on the molecular basis underlying the currently untreatable neurodevelopmental disorders.
